Pulmonary Effects of Methylprednisolone in Patients Undergoing Coronary Artery Bypass Grafting and Early Tracheal Extubation
- 1 July 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 87 (1) , 27-33
- https://doi.org/10.1213/00000539-199807000-00007
Abstract
Nary effects of methylprednisolone in patients undergoing coronary artery bypass grafting (CABG) and early tracheal extubation. Sixty patients undergoing elective CABG and early tracheal extubation were randomized into two groups. Group MP patients received IV methylprednisolone (30 mg/kg during sternotomy and 30 mg/kg during initiation of cardiopulmonary bypass) and Group NS patients received IV placebo at the same two times. Perioperative management was standardized. Alveolar-arterial (A-a) oxygen gradient, lung compliance, shunt, and dead space were determined four times perioperatively. Postoperative tracheal extubation was accomplished at the earliest appropriate time. Both groups exhibited significant postoperative increases in A-a oxygen gradient and shunt (P < 0.000001 for each group) and significant postoperative decreases in dynamic lung compliance (P < 0.000001 for each group). Patients in Group MP exhibited significantly larger increases in postoperative A-a oxygen gradient (P = 0.001) and shunt (P = 0.001) compared with patients in Group NS. Postoperative alterations in dynamic lung compliance, static lung compliance, and dead space were not statistically significant between the groups. The time to postoperative tracheal extubation was prolonged in Group MP patients compared with Group NS patients (769 +/- 294 vs 604 +/- 315 min, respectively; P = 0.05). Methylprednisolone was associated with larger increases in postoperative A-a oxygen gradient and shunt, was unable to prevent postoperative decreases in lung compliance, and prolonged extubation time, which indicate that use of the drug may hinder early tracheal extubation in patients after cardiac surgery. Implications: Traditionally, methylprednisolone has been administered to patients undergoing cardiac surgery to decrease postoperative pulmonary dysfunction. This study revealed that the drug is associated with larger increases in postoperative alveolararterial oxygen gradient and shunt and prolonged tracheal extubation time in patients undergoing coronary artery bypass grafting, which indicate that use of the drug may hinder early tracheal extubation. (Anesth Analg 1998;87:27-33)...Keywords
This publication has 30 references indexed in Scilit:
- Steroid administration in heart and heart—lung transplantation: Is the timing adequate?The Annals of Thoracic Surgery, 1996
- Ventilation-Perfusion Inequality in Patients Undergoing Cardiac SurgeryAnesthesiology, 1994
- Thoracic Intravascular and Extravascular Fluid Volumes in Cardiac Surgical PatientsAnesthesiology, 1993
- The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypassEuropean Journal of Cardio-Thoracic Surgery, 1991
- Effects of methylprednisolone on complement activation and leukocyte counts during cardiopulmonary bypassScandinavian Journal of Thoracic and Cardiovascular Surgery, 1987
- Complement activation during cardiopulmonary bypassAnaesthesia, 1980
- Lysosomal enzyme release from the lungs after cardiopulmonary bypassAnaesthesia, 1978
- The Effects of Methylprednisolone on the Complications of Coronary Artery SurgeryVascular Surgery, 1977
- Airway Closure and Distribution of Inspired Gas in the Extremely Obese, Breathing Spontaneously and During Anaesthesia with Intermittent Positive Pressure VentilationActa Anaesthesiologica Scandinavica, 1976
- Breathing Mechanics, Dead Space and Gas Exchange in the Extremely Obese, Breathing Spontaneously and During Anaesthesia with Intermittent Positive Pressure VentilationActa Anaesthesiologica Scandinavica, 1976